PubMed:10438913 / 587-708 JSONTXT

Annnotations TAB JSON ListView MergeView

    jnlpba-st-training

    {"project":"jnlpba-st-training","denotations":[{"id":"T13","span":{"begin":25,"end":29},"obj":"protein"},{"id":"T14","span":{"begin":56,"end":65},"obj":"protein"},{"id":"T15","span":{"begin":70,"end":74},"obj":"protein"},{"id":"T16","span":{"begin":87,"end":92},"obj":"protein"},{"id":"T17","span":{"begin":107,"end":120},"obj":"DNA"}],"text":"Promoter assays revealed CD28-dependent effects on both NF-kappaB and AP-1, but not on NF-AT or the intact IL-2 promoter."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C14","span":{"begin":25,"end":30},"obj":"NP"}],"text":"Promoter assays revealed CD28-dependent effects on both NF-kappaB and AP-1, but not on NF-AT or the intact IL-2 promoter."}

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S5","span":{"begin":0,"end":121},"obj":"Sentence"}],"text":"Promoter assays revealed CD28-dependent effects on both NF-kappaB and AP-1, but not on NF-AT or the intact IL-2 promoter."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T16","span":{"begin":25,"end":29},"obj":"protein_molecule"},{"id":"T17","span":{"begin":56,"end":65},"obj":"protein_complex"},{"id":"T18","span":{"begin":70,"end":74},"obj":"protein_molecule"},{"id":"T19","span":{"begin":87,"end":92},"obj":"protein_molecule"},{"id":"T20","span":{"begin":107,"end":111},"obj":"protein_molecule"}],"text":"Promoter assays revealed CD28-dependent effects on both NF-kappaB and AP-1, but not on NF-AT or the intact IL-2 promoter."}